• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同步性乳腺癌和甲状腺癌后孕期暴露于他莫昔芬的情况。

Tamoxifen exposure in pregnancy after synchronous breast and thyroid cancer.

作者信息

Athman Omar Abeid M, Abdel-Bary Amany, Elsaka Rasha O

机构信息

Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Alexandria University, Champlion Street, Alazarita, Alexandria 21131, Egypt.

https://orcid.org/0000-0003-4081-8547.

出版信息

Ecancermedicalscience. 2020 Oct 15;14:1125. doi: 10.3332/ecancer.2020.1125. eCollection 2020.

DOI:10.3332/ecancer.2020.1125
PMID:33209116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7652426/
Abstract

Thyroid and breast cancer are the most common cancers among young women, which are either synchronous or metachronous, but the association is yet to be elucidated. With the improvement of diagnosis and treatment, there is an increase in breast and thyroid cancer survivors. Hence, attention is shifting towards survivorship. Here, we report the case of a young lady diagnosed with synchronous thyroid and breast cancer who unexpectedly became pregnant during tamoxifen treatment. After a multidisciplinary discussion, endocrine therapy was interrupted and she delivered a healthy baby at term. In conclusion, oncologists should be aware of breast and thyroid cancer co-occurrence and examinations should be conducted together in diagnosis and follow-up. Also, pregnancy is feasible and can be considered after synchronous breast and thyroid cancer diagnosis. Physicians need to emphasise the use of barrier contraceptives to patients undergoing endocrine therapy. However, the optimum timing for pregnancy after breast cancer and the safety of endocrine therapy interruption in hormonal-positive patients should be discussed and managed by a multidisciplinary team.

摘要

甲状腺癌和乳腺癌是年轻女性中最常见的癌症,它们可以是同时发生的,也可以是异时发生的,但两者之间的关联尚待阐明。随着诊断和治疗水平的提高,乳腺癌和甲状腺癌幸存者的数量有所增加。因此,关注点正转向生存问题。在此,我们报告一例年轻女性同时被诊断出患有甲状腺癌和乳腺癌的病例,该患者在接受他莫昔芬治疗期间意外怀孕。经过多学科讨论,中断了内分泌治疗,她足月产下一名健康婴儿。总之,肿瘤学家应意识到乳腺癌和甲状腺癌的同时发生,在诊断和随访中应同时进行检查。此外,怀孕是可行的,在同时诊断出乳腺癌和甲状腺癌后可以考虑怀孕。医生需要向接受内分泌治疗的患者强调使用屏障避孕法。然而,乳腺癌后怀孕的最佳时机以及激素阳性患者中断内分泌治疗的安全性,应由多学科团队进行讨论和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b778/7652426/c36f92ba2f12/can-14-1125fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b778/7652426/8e34b4a5af09/can-14-1125fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b778/7652426/c36f92ba2f12/can-14-1125fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b778/7652426/8e34b4a5af09/can-14-1125fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b778/7652426/c36f92ba2f12/can-14-1125fig2.jpg

相似文献

1
Tamoxifen exposure in pregnancy after synchronous breast and thyroid cancer.同步性乳腺癌和甲状腺癌后孕期暴露于他莫昔芬的情况。
Ecancermedicalscience. 2020 Oct 15;14:1125. doi: 10.3332/ecancer.2020.1125. eCollection 2020.
2
Breast cancer, pregnancy, and breastfeeding.乳腺癌、妊娠与母乳喂养。
J Obstet Gynaecol Can. 2002 Feb;24(2):164-80; quiz 181-4.
3
Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era.他莫昔芬时代激素阳性乳腺癌诊断及后续妊娠后的乳腺癌预后
Clin Breast Cancer. 2017 Jul;17(4):e185-e189. doi: 10.1016/j.clbc.2016.12.014. Epub 2017 Jan 9.
4
Hormones and breast cancer.激素与乳腺癌
Am J Surg. 1989 Apr;157(4):438-42. doi: 10.1016/0002-9610(89)90596-5.
5
Metachronous Cancer of Breast and Adenocarcinoma of Cervix: A Rare Case Report.异时性乳腺癌和宫颈癌:一例罕见病例报告
J Menopausal Med. 2017 Aug;23(2):131-134. doi: 10.6118/jmm.2017.23.2.131. Epub 2017 Aug 31.
6
[Multidisciplinary cooperation strengthens individualized management of breast cancer in pregnancy].
Zhonghua Wai Ke Za Zhi. 2020 Feb 1;58(2):95-98. doi: 10.3760/cma.j.issn.0529-5815.2020.02.004.
7
Synchronous primary cancers of the thyroid and breast: A case report and review of the literature.甲状腺和乳腺同步原发性癌:一例病例报告及文献综述
Oncol Lett. 2015 Jan;9(1):351-354. doi: 10.3892/ol.2014.2625. Epub 2014 Oct 17.
8
Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables.分化型甲状腺癌背景下的双原发恶性肿瘤:其同时性或异时性特征、放射性碘治疗对第二原发恶性肿瘤发生的影响及其他相关变量。
Nucl Med Commun. 2014 Feb;35(2):205-9. doi: 10.1097/MNM.0000000000000033.
9
Risk Factors of Synchronous Breast and Thyroid Cancer: a Controlled Multicenter Study and Review of the Literature.同步性乳腺癌和甲状腺癌的危险因素:一项对照多中心研究及文献综述
Mater Sociomed. 2021 Dec;33(4):298-303. doi: 10.5455/msm.2021.33.298-303.
10
A Linkage Between Thyroid and Breast Cancer: A Common Etiology?甲状腺癌与乳腺癌的关联:共同的病因?
Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):643-649. doi: 10.1158/1055-9965.EPI-18-0877. Epub 2018 Dec 12.

本文引用的文献

1
Distribution and Prognostic Significance of Estrogen Receptor (ER), Estrogen Receptor (ER), and Human Epidermal Growth Factor Receptor 2 (HER-2) in Thyroid Carcinoma.雌激素受体(ER)、雌激素受体(ER)和人表皮生长因子受体2(HER-2)在甲状腺癌中的分布及预后意义
J Thyroid Res. 2020 May 5;2020:6935724. doi: 10.1155/2020/6935724. eCollection 2020.
2
Tamoxifen Exposure during Pregnancy: A Systematic Review and Three More Cases.孕期暴露于他莫昔芬:一项系统评价及另外三例病例报告
Breast Care (Basel). 2020 Apr;15(2):148-156. doi: 10.1159/000501473. Epub 2019 Jul 25.
3
ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4).
ESO-ESMO 4 版年轻女性乳腺癌国际共识指南(BCY4)。
Ann Oncol. 2020 Jun;31(6):674-696. doi: 10.1016/j.annonc.2020.03.284. Epub 2020 Mar 19.
4
Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.乳腺癌幸存者合并甲状腺癌的临床病理特征、生存和风险:SEER 数据库分析。
BMC Public Health. 2019 Nov 29;19(1):1592. doi: 10.1186/s12889-019-7947-y.
5
Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer.患有甲状腺癌病史的患者乳腺癌特异性死亡率降低。
PLoS One. 2019 Oct 23;14(10):e0221093. doi: 10.1371/journal.pone.0221093. eCollection 2019.
6
Effects of phytoestrogens on the activity and growth of primary breast cancer cells ex vivo.植物雌激素对原发性乳腺癌细胞体外活性和生长的影响。
J Obstet Gynaecol Res. 2019 Jul;45(7):1352-1362. doi: 10.1111/jog.13982. Epub 2019 May 16.
7
Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations.甲状腺乳头状癌:遗传改变与分子生物标志物研究。
Int J Med Sci. 2019 Feb 28;16(3):450-460. doi: 10.7150/ijms.29935. eCollection 2019.
8
A Linkage Between Thyroid and Breast Cancer: A Common Etiology?甲状腺癌与乳腺癌的关联:共同的病因?
Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):643-649. doi: 10.1158/1055-9965.EPI-18-0877. Epub 2018 Dec 12.
9
Association between breast cancer and thyroid cancer: A study based on 13 978 patients with breast cancer.乳腺癌与甲状腺癌的相关性:基于 13978 例乳腺癌患者的研究。
Cancer Med. 2018 Dec;7(12):6393-6400. doi: 10.1002/cam4.1856. Epub 2018 Nov 27.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.